Latest Breaking News On - Ardelyx patient advisory council - Page 1 : comparemela.com

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDerek forfangDavid spiegelTenapanor monotherapyLaura williamsArnold silvaDrug administration onAmerican society of nephrologyBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican societyKidney weekExhibitor spotlightDrug administration

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArnold silvaTenapanor monotherapyFosun pharmaDerek forfangDavid spiegelLaura williamsCaitlin lowieKimia keshtbodBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican society of nephrologyDrug administration onAmerican society

Ardelyx Shares Positive Data from Studies of XPHOZAH (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03.11.2023 - WALTHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) - Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical . Seite 1

United statesDerek forfangArdelyx patient advisory councilDrug administration onAmerican society of nephrologyArdelyx incAmerican societyKidney weekExhibitor spotlightDrug administrationArdelyx chartRdelyx kursRdelyx aktie

National Kidney Foundation and Ardelyx, Inc Survey Finds Dialysis Patients Struggle to Maintain Serum Phosphorus Levels

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX) in partnership with the National Kidney Foundation (NKF), today announced results from a survey of patients with.

Joseph vassalottiLauraa williamsPrnewswire ardelyx incNational kidney foundationArdelyx incArdelyx patient advisory councilPatient advisory councilNational kidney